Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 1;14(11):2755. doi: 10.3390/cancers14112755

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effect of BET inhibitors JQ1 and GSK1324726A and of CDK inhibitors THZ1, YKL-5-15, and THZ531 on the proliferation of chromaffin cells, neuroblasts, and NESTIN-expressing cells (NECs). Dose–response curves are shown for the BET inhibitors JQ1 (A) and CSK1324726A (B), CDK7 inhibitors THZ1 (C) and YKL-5-15 (D) and the CDK12/13 inhibitor THZ531 (E), Data represent the mean ± s.e.m. of at least three independent experiments. Significant differences marked by * and ** indicate p-values < 0.05 and <0.01, respectively.

Effect of BET inhibitors JQ1 and GSK1324726A and of CDK inhibitors THZ1, YKL-5-15, and THZ531 on the proliferation of chromaffin cells, neuroblasts, and NESTIN-expressing cells (NECs). Dose–response curves are shown for the BET inhibitors JQ1 (A) and CSK1324726A (B), CDK7 inhibitors THZ1 (C) and YKL-5-15 (D) and the CDK12/13 inhibitor THZ531 (E), Data represent the mean ± s.e.m. of at least three independent experiments. Significant differences marked by * and ** indicate p-values < 0.05 and <0.01, respectively.